Patents by Inventor RU-FANG YEH

RU-FANG YEH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150056190
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: March 14, 2013
    Publication date: February 26, 2015
    Applicant: Genentech, Inc.
    Inventors: Priti Hegde, Maike Schmidt, Ru-Fang Yeh
  • Publication number: 20140017230
    Abstract: The present application describes chronic lymphocytic leukemia (CLL) biomarkers. In particular, the invention concerns miRNA151 3p, miRNA409 3p, PTK2, and/or PI3K as biomarkers for patient selection in CLL, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, and methods of advertising related thereto.
    Type: Application
    Filed: February 1, 2013
    Publication date: January 16, 2014
    Applicants: HOFFMANN-LA ROCHE INC., GENENTECH, INC.
    Inventors: DAVID DORNAN, GUILLEMETTE DUCHATEAU-NGUYEN, TRI QUANG NGUYEN, GIUSEPPE PALERMO, MARTIN WEISSER, RU-FANG YEH